Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
CRISPR Therapeutics AG
CRSP
Healthcare
Biotechnology
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company’s CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has...
a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR T cell therapies, in vivo, and type 1 diabetes, as well as develops investigational CAR T programs, including an autologous, gene-edited CAR T program targeting glypican-3 (GPC3) for the potential treatment of solid tumors. The company’s lead product candidate is CASGEVY, an ex vivo CRISPR/Cas9 gene-edited cell therapy for treating patients suffering from transfusion-dependent beta-thalassemia, severe sickle cell disease (SCD), and hemoglobinopathies in which a patient’s hematopoietic stem a...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:CRSP)
New Post
View:
Posts & Comments
Threaded Posts
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 02, 2024 3:54pm
CRISPR Therapeutics AG (NASDAQ:CRSP): A Pioneering Gene Edit
https://beyondspx.com/2024/07/31/crispr-therapeutics-ag-nasdaqcrsp-a-pioneering-gene-editing-company-poised-for-continued-growth/
(2)
•••
CreatingApe
X
Comment by
CreatingApe
on May 08, 2024 7:01pm
RE:regrets
Lol if you think it's a 1000 dollar stock it's definitely not too late. 52.22 at close today...
Scaling for long-term success: A new era in gold development
posted Dec 11, 2025 9:00am by
Vista Gold Corp.
-
|
Backed by years of technical expertise and strategic discipline, Mt Todd has emerged as one of the most compelling undeveloped gold assets globally. A recently completed feasibility study signals a pivotal shift in strategy ...read more
(104)
•••
foofadooo
X
Comment by
foofadooo
on Aug 25, 2022 8:19am
RE: Switzerland-based biotechnology leader
Eventually, it will be like owning a solid ETF. I view it similar to an ARKK or TSLA....it just requires some long term paitience! foof
(2)
•••
jw1trader
X
Post by
jw1trader
on Aug 24, 2022 12:51pm
Switzerland-based biotechnology leader
portfolio of therapies across a range of disease areas, including treatments for blood disorders, specialized cancers and other rare conditions. With strategic partnerships that include major players
...more
(4)
•••
Lisaslab
X
Post by
Lisaslab
on Aug 24, 2022 12:44pm
$4 billion CRISPR is a Switzerland-based biotechnology
biotechnology leader known for its cutting-edge platform to support gene editing and related development of genomic DNA medicines. It has a portfolio of therapies across a range of disease areas
...more
(104)
•••
foofadooo
X
Comment by
foofadooo
on Aug 19, 2021 7:25am
RE:regrets
IMHO.....it's not to late there will br many growth stocks springboard off CRSPR....CRBU... is a good example... foof
(1)
•••
phred7
X
Post by
phred7
on Dec 10, 2020 12:56am
regrets
I have been following this and 2 other CRISPR stocks for over 4 years... wow did I make a mistake. I did not buy. This is a health care bite me stock. I wish I had the 20/20 when the
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Lode Gold Enters into Exclusive LOI with a Mining Company to Advance Fremont Gold Project
Mt Todd has emerged as one of the most compelling undeveloped gold assets globally